It has also been demonstrated that flotillin-1 plays an important role in cellular proliferation, and its increased expression correlates with poor outcome in patients with breast cancer and lung adenocarcinomas [6-8]. The gene discussed is FLOT1; the disease is lung adenocarcinoma.